| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.1 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.2 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.2 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.077 | 0.2 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |